Fengxue Qin

Statistics

Publications

Citations

105

H-Index

Active since

2020

Affiliations

Affiliated Hospital of Youjiang Medical University for Nationalities(Current)

Fengxue Qin is an author at Affiliated Hospital of Youjiang Medical University for Nationalities specializing in noncoding rna in cancer, molecular oncology, and natural product-based drug design.

Publications per year

2020–2023

Publications

LncRNA LL22NC03-N14H11.1 promoted hepatocellular carcinoma progression through activating MAPK pathway to induce mitochondrial fission

Tingzhuang Yi, Hongcheng Luo, Fengxue Qin et al. · Cell Death and Disease · 2020 · 44 citations · Full text

Medicine, Cancer Biology, Oncology +17

lncRNA PRR34-AS1 promotes HCC development via modulating Wnt/β-catenin pathway by absorbing miR-296-5p and upregulating E2F2 and SOX12

Minzhen Qin, Yiliang Meng, Chunying Luo et al. · Molecular Therapy — Nucleic Acids · 2021 · 40 citations · Full text

Life Sciences, Genetics, Molecular Biology +16

Design, synthesis, and biological evaluation of novel capsaicin-tacrine hybrids as multi-target agents for the treatment of Alzheimer's disease

Juan‐yue Long, Fengxue Qin, Jinchong Luo et al. · Bioorganic Chemistry · 2023 · 21 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

1–3 of 3